Anna Millqvist-Fureby
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anna Millqvist-Fureby has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
Björn Bergenståhl
10 shared publicationsMichael Schuleit
Novartis Pharma AG, Novartis Institutes for Biomedical Research, GDC, Novartis Campus, 4002, Basel, Switzerland
7 shared publications- Evgeny N. Vulfson
Institute of Food Research, Norwich Research Park, Colney Lane, Norwich, NR4 7UA, UK; telephone: 44‐1603‐255093; fax: 44‐1603‐507723
4 shared publications Niklas Nordgren
RISE Research Intitutes of Sweden, Division of Bioscience and Materials, Box 5607, SE-114 86Stockholm, Sweden
4 shared publications- Patrick Adlercreutz
Division of Biotechnology, Department of Chemistry, Lund University, Lund, Sweden
4 shared publications Ulla Elofsson
4 shared publications
Latest Publications
- Open Access
- 31 July 2025
- Published by Elsevier in Food Hydrocolloids
- Vol. 171
Starch microsphere preparation and phase behaviour in aqueous two-phase systems – effect of continuous-phase polymer
- 31 July 2025
- Published by Elsevier in Food Hydrocolloids
- Vol. 171
Open AccessStarch microsphere preparation and phase behaviour in aqueous two-phase systems – effect of continuous-phase polymer
- Open Access
- 19 April 2025
- Published by Elsevier in Food Hydrocolloids
- Vol. 168
Investigating the dynamics of freeze-drying and annealing using in-situ synchrotron X-ray microtomography
- 19 April 2025
- Published by Elsevier in Food Hydrocolloids
- Vol. 168
Open AccessInvestigating the dynamics of freeze-drying and annealing using in-situ synchrotron X-ray microtomography
- Open Access
- 28 October 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 667 (Pt A) , 124883
Exploring vacuum foam drying as an alternative to freeze-drying and spray drying for a human lipase
- 28 October 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 667 (Pt A) , 124883
Open AccessExploring vacuum foam drying as an alternative to freeze-drying and spray drying for a human lipase
- Open Access
- 1 January 2024
- Published by Oxford University Press (OUP) in International Journal for Quality in Health Care
- Vol. 36 (1)
How are we handling protein drugs in hospitals? A human factors and systems engineering approach to compare two hospitals and suggest a best practice
Biopharmaceuticals are complex biological molecules that require careful storage and handling to ensure medication integrity. In this study, a work system analysis of real-world protein drug (PD) handling was performed with the following goals: identify main barriers and facilitators for successful adherence to accepted recommendations in PD handling, analyse differences in two organizations, and define a Best Current Practice in the real-life handling of PDs based on the results of the work system analysis. Observational study was held in two university hospitals in Spain and Sweden. Based on the Systems Engineering Initiative for Patient Safety (SEIPS) model, the tools chosen were: the PETT scan, in order to indicate the presence of barriers or facilitators for the PETT components (People, Environment, Tools, Tasks); the Tasks and tools matrices to construct a checklist to record direct observations during the real-life handling of biopharmaceuticals, and the Journey map to depict the work process. Observations were performed between March and November 2022. Each episode of direct observation included a single protein drug in some point of the supply chain and considered all the elements in the work system. Based on the results of the work system analysis and the literature review, the authors propose a list of items which could be assumed as Best Current Practice for PDs handling in hospitals. There were a total of 34 observations involving 19 PDs. Regarding People involved in the work process, there was a diversity of professionals with different previous training and knowledge, leading to an information gap. With respect to Environment, some structural and organizational differences between hospitals lead to risks related to the time exposure of PDs to room temperature and mechanical stress. Some differences also existed in the Tools and Tasks involved in the process, being especially relevant to the lack of compatibility information of PDs with new technologies, such as pneumatic tube system, robotic reconstitution, or closed-system transfer devices. Finally, 15 suggestions for best current practice are proposed. Main barriers found for compliance with accepted recommendations were related to the information gap detected in professionals involved in the handling of protein drugs, unmonitored temperature, and the lack of compatibility information of protein drugs with some new technologies. By applying a Human Factors and Systems Engineering Approach, the comparison of two European hospitals has led to a suggested list of Best Current Practices in the handling of protein drugs in a hospital.
- 1 January 2024
- Published by Oxford University Press (OUP) in International Journal for Quality in Health Care
- Vol. 36 (1)
Open AccessHow are we handling protein drugs in hospitals? A human factors and systems engineering approach to compare two hospitals and suggest a best practice
Biopharmaceuticals are complex biological molecules that require careful storage and handling to ensure medication integrity. In this study, a work system analysis of real-world protein drug (PD) handling was performed with the following goals: identify main barriers and facilitators for successful adherence to accepted recommendations in PD handling, analyse differences in two organizations, and define a Best Current Practice in the real-life handling of PDs based on the results of the work system analysis. Observational study was held in two university hospitals in Spain and Sweden. Based on the Systems Engineering Initiative for Patient Safety (SEIPS) model, the tools chosen were: the PETT scan, in order to indicate the presence of barriers or facilitators for the PETT components (People, Environment, Tools, Tasks); the Tasks and tools matrices to construct a checklist to record direct observations during the real-life handling of biopharmaceuticals, and the Journey map to depict the work process. Observations were performed between March and November 2022. Each episode of direct observation included a single protein drug in some point of the supply chain and considered all the elements in the work system. Based on the results of the work system analysis and the literature review, the authors propose a list of items which could be assumed as Best Current Practice for PDs handling in hospitals. There were a total of 34 observations involving 19 PDs. Regarding People involved in the work process, there was a diversity of professionals with different previous training and knowledge, leading to an information gap. With respect to Environment, some structural and organizational differences between hospitals lead to risks related to the time exposure of PDs to room temperature and mechanical stress. Some differences also existed in the Tools and Tasks involved in the process, being especially relevant to the lack of compatibility information of PDs with new technologies, such as pneumatic tube system, robotic reconstitution, or closed-system transfer devices. Finally, 15 suggestions for best current practice are proposed. Main barriers found for compliance with accepted recommendations were related to the information gap detected in professionals involved in the handling of protein drugs, unmonitored temperature, and the lack of compatibility information of protein drugs with some new technologies. By applying a Human Factors and Systems Engineering Approach, the comparison of two European hospitals has led to a suggested list of Best Current Practices in the handling of protein drugs in a hospital.
- Open Access
- 7 May 2023
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 112 (11) , 2799-2810
Examination of the Protein Drug Supply Chain in a Swedish University Hospital: Focus on Handling Risks and Mitigation Measures
- 7 May 2023
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 112 (11) , 2799-2810
Open AccessExamination of the Protein Drug Supply Chain in a Swedish University Hospital: Focus on Handling Risks and Mitigation Measures
- Open Access
- 1 February 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (7) , 2030-2037
Influence of Cooling Rate on Ice Crystallization and Melting in Sucrose-Water System
- 1 February 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (7) , 2030-2037
Open AccessInfluence of Cooling Rate on Ice Crystallization and Melting in Sucrose-Water System
- Open Access
- 1 July 2018
- Published by Elsevier in Food Research International
- Vol. 109, 448-454
Morphology development during single droplet drying of mixed component formulations and milk
- 1 July 2018
- Published by Elsevier in Food Research International
- Vol. 109, 448-454
Open AccessMorphology development during single droplet drying of mixed component formulations and milk
- 2 June 2018
- Published by Elsevier in International Dairy Journal
- Vol. 85, 86-95
Impact of surface properties on morphology of spray-dried milk serum protein/lactose systems
- 2 June 2018
- Published by Elsevier in International Dairy Journal
- Vol. 85, 86-95
Impact of surface properties on morphology of spray-dried milk serum protein/lactose systems